Temitope S Oladejo, Hellen Myezwa, Adedayo T Ajidahun, Sam Ibeneme
{"title":"Prevalence and predictors of HIV-related disability among people living with HIV in Nigeria.","authors":"Temitope S Oladejo, Hellen Myezwa, Adedayo T Ajidahun, Sam Ibeneme","doi":"10.4102/sajp.v80i1.2001","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>People living with human immunodeficiency virus (PLWH) live longer, but experience human immunodeficiency virus (HIV)-related comorbidities and disabilities that lower their quality of life. Understanding the prevalence, risk factors, and disability patterns is crucial for tailored interventions.</p><p><strong>Objectives: </strong>To explore the prevalence and predictors of HIV-related disability among PLWH in Nigeria.</p><p><strong>Method: </strong>This cross-sectional survey involved 385 PLWH, exploring demographic data, HIV history, recent symptoms, disability (measured by the WHO Disability Assessment Schedule-WHODAS 2.0). Descriptive statistics summarised the data, all variables were entered into univariate and multivariate regression models. IBM SPSS 25<sup>®</sup> was used for all analyses at a 95% confidence level.</p><p><strong>Results: </strong>The prevalence of disability among PLWH was 39.5%, the mean age was 42.2 ± 10.43 years, and 73% of the participants were females. Factors significantly associated with disability were marital status (<i>p</i> = 0.009) and level of education (<i>p</i> = 0.001).</p><p><strong>Conclusion: </strong>The study reveals a prevalence of disability (39.5%) among PLWH on antiretroviral therapy (ART), emphasising the need for tailored interventions considering socio-demographic factors. Continuous screening, risk identification, and effective management strategies are imperative, recognising disability as an indicator of health and quality of life.</p><p><strong>Clinical implications: </strong>With PLWH experiencing increased life expectancy, the study underscores the need for an informed patient-centred approach to care, recognising the specific challenges faced by PLWH in Nigeria and guiding the development of targeted interventions to enhance both functional outcomes and overall well-being.</p>","PeriodicalId":44180,"journal":{"name":"South African Journal of Physiotherapy","volume":null,"pages":null},"PeriodicalIF":1.0000,"publicationDate":"2024-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11304381/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"South African Journal of Physiotherapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4102/sajp.v80i1.2001","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"REHABILITATION","Score":null,"Total":0}
引用次数: 0
Abstract
Background: People living with human immunodeficiency virus (PLWH) live longer, but experience human immunodeficiency virus (HIV)-related comorbidities and disabilities that lower their quality of life. Understanding the prevalence, risk factors, and disability patterns is crucial for tailored interventions.
Objectives: To explore the prevalence and predictors of HIV-related disability among PLWH in Nigeria.
Method: This cross-sectional survey involved 385 PLWH, exploring demographic data, HIV history, recent symptoms, disability (measured by the WHO Disability Assessment Schedule-WHODAS 2.0). Descriptive statistics summarised the data, all variables were entered into univariate and multivariate regression models. IBM SPSS 25® was used for all analyses at a 95% confidence level.
Results: The prevalence of disability among PLWH was 39.5%, the mean age was 42.2 ± 10.43 years, and 73% of the participants were females. Factors significantly associated with disability were marital status (p = 0.009) and level of education (p = 0.001).
Conclusion: The study reveals a prevalence of disability (39.5%) among PLWH on antiretroviral therapy (ART), emphasising the need for tailored interventions considering socio-demographic factors. Continuous screening, risk identification, and effective management strategies are imperative, recognising disability as an indicator of health and quality of life.
Clinical implications: With PLWH experiencing increased life expectancy, the study underscores the need for an informed patient-centred approach to care, recognising the specific challenges faced by PLWH in Nigeria and guiding the development of targeted interventions to enhance both functional outcomes and overall well-being.